| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |